Detalhe da pesquisa
1.
Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study.
J Antimicrob Chemother
; 73(8): 2120-2128, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29905808
2.
Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight).
J Antimicrob Chemother
; 73(8): 2129-2136, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29860402